glp 1 agonist news GLP-1 receptor agonists show promise in treating substance use disorders A clinician's perspective π GLP-1
Description
10.1212/wnl.0000000000213447 75 SiddeequeN.HusseinM
The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis
doi:10.1016/j.cmet.2018.03.001
The best-supported benefits are weight reduction, BMI reduction, improved insulin resistance, and some improvements in androgen-related markers
Best for: People looking at the global pipeline of alternatives and considering future options with strong metabolic profiles
